Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000712003 | SCV000616819 | uncertain significance | not provided | 2017-10-30 | criteria provided, single submitter | clinical testing | The V274F variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant is observed in 15/16078 (0.09%) alleles from individuals of Latino background in large population cohorts (Lek et al., 2016). V274F is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved, and in silico analysis predicts this variant likely does not alter the protein structure/function. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Athena Diagnostics | RCV000712003 | SCV000842416 | uncertain significance | not provided | 2019-07-30 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821454 | SCV002070606 | uncertain significance | not specified | 2019-10-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490898 | SCV002797002 | uncertain significance | Maturity-onset diabetes of the young type 4; Pancreatic agenesis 1; Type 2 diabetes mellitus | 2022-01-04 | criteria provided, single submitter | clinical testing |